<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nid-3749</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МАТЕРИАЛЫ III МЕЖДУНАРОДНОГО СЕМИНАРА ПО НЕФРОЛОГИИ</subject></subj-group></article-categories><title-group><article-title>Ингибиторы ангиотензин-конвертирующего фермента и блокаторы рецепторов ангиотензина II: уникальные препараты для защиты почки и сердечно-сосудистой системы</article-title><trans-title-group xml:lang="en"><trans-title>ACEIs and ARB: Unique drugs for protection of the kidney and cardiovascular system</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кристофер</surname><given-names>С. Вилкокс</given-names></name><name name-style="western" xml:lang="en"><surname>Christopher</surname><given-names>S. Wilcox</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>доктор медицины и философии Руководитель Отдела Нефрологии и Гипертонии Университетского Медицинского Центра Джорджтаун</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M. D., Ph. D. Chief, Division of Nephrology and Hypertension Georgetown University Medical Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2000</year></pub-date><pub-date pub-type="epub"><day>28</day><month>06</month><year>2025</year></pub-date><volume>2</volume><issue>4</issue><fpage>236</fpage><lpage>240</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кристофер С.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Кристофер С.В.</copyright-holder><copyright-holder xml:lang="en">Christopher S.W.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/3749">https://journal.nephro.ru/jour/article/view/3749</self-uri><abstract><p>Эффективность ИАПФ у больных с хронической сердечной недостаточностью (ХСН) была изучена в семи контролированных рандомизированных исследованиях. Они показали, что эти препараты у таких больных значимо влияют на летальность. Действие ИАПФ усиливало любое благоприятное воздействие, опосредованное через снижение АД, и оно было максимальным у пациентов с наиболее тяжелой ХСН. * Перевод A.P. Багдасарян</p></abstract><kwd-group xml:lang="ru"><kwd>ингибиторы АПФ</kwd><kwd>блокаторы рецепторов ангиотензина II</kwd><kwd>сердечно-сосудистые заболевания</kwd><kwd>диабетическая нефропатия</kwd><kwd>прогрессирование нефропатий</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Wilcox C.S. Use of angiotensin-converting-enzyme inhibitors for diagnosing renovascular hypertension. Kidney Int. 44: 1379-1390, 1993.</mixed-citation><mixed-citation xml:lang="en">Wilcox C.S. Use of angiotensin-converting-enzyme inhibitors for diagnosing renovascular hypertension. Kidney Int. 44: 1379-1390, 1993.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Muller F.B., Sealey J.E., Case D.B., Atlas S.A., Pickering T.G. and Pecker M.S. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 80: 633-644, 1986.</mixed-citation><mixed-citation xml:lang="en">Muller F.B., Sealey J.E., Case D.B., Atlas S.A., Pickering T.G. and Pecker M.S. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 80: 633-644, 1986.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Frederickson E.D., Wilcox C.S., Bucci C.M., Loon N.R., Peterson J.C., Brown N.L., Thompson R.D., Smith T.B. and Wingo C.S. A prospective evaluation of a simplified captopril test for the detection of renovascular hypertension. Arch. Intern. Med. 150: 569-572, 1990.</mixed-citation><mixed-citation xml:lang="en">Frederickson E.D., Wilcox C.S., Bucci C.M., Loon N.R., Peterson J.C., Brown N.L., Thompson R.D., Smith T.B. and Wingo C.S. A prospective evaluation of a simplified captopril test for the detection of renovascular hypertension. Arch. Intern. Med. 150: 569-572, 1990.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Fommei E., Ghione S., Hilson A.J.W., Mezzasalma H.Y., Oei H.-Y., Volterrani D. and The European Multicentre Study Group. Captopril radionuclide test in renovascular hypertension: a European multicentre study. EurJNuc Med 20: 617-623,1993.</mixed-citation><mixed-citation xml:lang="en">Fommei E., Ghione S., Hilson A.J.W., Mezzasalma H.Y., Oei H.-Y., Volterrani D. and The European Multicentre Study Group. Captopril radionuclide test in renovascular hypertension: a European multicentre study. EurJNuc Med 20: 617-623,1993.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nally J., Chen C., Fine E., Fommei E., Ghione S., Geyskes G., Hoffer P.B. and Sfakianakis G. Diagnostic criteria of renovascular hypertension with captopril renography: a consensus statement. Am J Hypertens 4: 7495-7525, 1991.</mixed-citation><mixed-citation xml:lang="en">Nally J., Chen C., Fine E., Fommei E., Ghione S., Geyskes G., Hoffer P.B. and Sfakianakis G. Diagnostic criteria of renovascular hypertension with captopril renography: a consensus statement. Am J Hypertens 4: 7495-7525, 1991.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Prigent A. The diagnosis of renovascular hypertension: the role of captopril renal scintigraphy and related issues. Eur J Nuc Med 20, 625-644. 1993.</mixed-citation><mixed-citation xml:lang="en">Prigent A. The diagnosis of renovascular hypertension: the role of captopril renal scintigraphy and related issues. Eur J Nuc Med 20, 625-644. 1993.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Black H.R., Bourgoignie J.J., Pickering T., Svetkey L., Saddler M.C., Setaro F.J. and Textor S.C. Report of the working party group for patient selection and preparation. Am J Hypertens 4: 7455-7465, 1991.</mixed-citation><mixed-citation xml:lang="en">Black H.R., Bourgoignie J.J., Pickering T., Svetkey L., Saddler M.C., Setaro F.J. and Textor S.C. Report of the working party group for patient selection and preparation. Am J Hypertens 4: 7455-7465, 1991.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Erbsloh-Moller B., Dumas A., Roth D., Sfakianakis G.N. and Bourgoignie J.J. Furosemide-^’I-hippuran renography after angiotensin-converting enzyme inhibition for the diagnosis of renovascular hypertension. Am. J. Med. 90: 23-29, 1991.</mixed-citation><mixed-citation xml:lang="en">Erbsloh-Moller B., Dumas A., Roth D., Sfakianakis G.N. and Bourgoignie J.J. Furosemide-^’I-hippuran renography after angiotensin-converting enzyme inhibition for the diagnosis of renovascular hypertension. Am. J. Med. 90: 23-29, 1991.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Krijnen P., van Jaarsveld B., Steyerberg E.W., Man in’t Veld A.J. and Schalekamp M.A. A clinical prediction rule for renal artery stenosis. Ann Intern Med 129: 705-711, 1998.</mixed-citation><mixed-citation xml:lang="en">Krijnen P., van Jaarsveld B., Steyerberg E.W., Man in’t Veld A.J. and Schalekamp M.A. A clinical prediction rule for renal artery stenosis. Ann Intern Med 129: 705-711, 1998.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Krumme B., Blum U., Schwertfeger E., Flugel P., Hollstin F., Schollmeyer P. and Rump L.C. Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning. Kid. International 50: 1288-1292, 1996.</mixed-citation><mixed-citation xml:lang="en">Krumme B., Blum U., Schwertfeger E., Flugel P., Hollstin F., Schollmeyer P. and Rump L.C. Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning. Kid. International 50: 1288-1292, 1996.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Appel R.G., Bleyer A.J., S. Reavis and Hansen K.J. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int. 48: 171-176, 1995.</mixed-citation><mixed-citation xml:lang="en">Appel R.G., Bleyer A.J., S. Reavis and Hansen K.J. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int. 48: 171-176, 1995.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Olbright C.J., Katrin P., Prokop M., Chavan A., Schaefer-Prokop C.M., Jandeleit K., Koch K.M. and Galanski M. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int. 48: 1332-1337, 1995.</mixed-citation><mixed-citation xml:lang="en">Olbright C.J., Katrin P., Prokop M., Chavan A., Schaefer-Prokop C.M., Jandeleit K., Koch K.M. and Galanski M. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int. 48: 1332-1337, 1995.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lerman L.О., Taler S.J., Textor S.C., Sheedy P.F., Stanson A.W. and Romero J.C. Computed tomography-derived intrarenal blood flow in renovascular and essential hypertension. Kidney Int. 49: 846-854, 1996.</mixed-citation><mixed-citation xml:lang="en">Lerman L.О., Taler S.J., Textor S.C., Sheedy P.F., Stanson A.W. and Romero J.C. Computed tomography-derived intrarenal blood flow in renovascular and essential hypertension. Kidney Int. 49: 846-854, 1996.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Choyke P.L., Austin H.A., Frank J.A., Girton M.E., Diggs R.L., Dwyer A.J., Miller L., Nussenblatt R., McFarland H. and Simon T. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Kidney Int. 41: 1595-1598,1992.</mixed-citation><mixed-citation xml:lang="en">Choyke P.L., Austin H.A., Frank J.A., Girton M.E., Diggs R.L., Dwyer A.J., Miller L., Nussenblatt R., McFarland H. and Simon T. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Kidney Int. 41: 1595-1598,1992.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ros P.R., Ganger J., Stoupis C., Burton S.S., Mao J., Wilcox C.S. and Briggs R. Magnetic resonance angiography combined with gadopentetate dimeglumine magnetic resonance imaging renography for the diagnosis of renovascular hypertension. Radiol. 1995.</mixed-citation><mixed-citation xml:lang="en">Ros P.R., Ganger J., Stoupis C., Burton S.S., Mao J., Wilcox C.S. and Briggs R. Magnetic resonance angiography combined with gadopentetate dimeglumine magnetic resonance imaging renography for the diagnosis of renovascular hypertension. Radiol. 1995.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Postma C.T., Joosten F.B.M., Rosenbusch G. and Thein T. Magnetic resonance angiography has a high reliability in the detection of renal artery stenosis. Am J. Hypertens. 10: 957-963, 1997.</mixed-citation><mixed-citation xml:lang="en">Postma C.T., Joosten F.B.M., Rosenbusch G. and Thein T. Magnetic resonance angiography has a high reliability in the detection of renal artery stenosis. Am J. Hypertens. 10: 957-963, 1997.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lawrence W.F., Grist T.M., Brazy P.C. and Fryback D.G. Magnetic resonance angiography in progressive renal failure: A technology assessment. Am. J. Kidney Dis. 25: 701-709, 1995.</mixed-citation><mixed-citation xml:lang="en">Lawrence W.F., Grist T.M., Brazy P.C. and Fryback D.G. Magnetic resonance angiography in progressive renal failure: A technology assessment. Am. J. Kidney Dis. 25: 701-709, 1995.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
